ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,201Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 917

$939K Total Retail Price of All Prescriptions

Rank: 20 out of 917

547 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 14,621 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 1,275 1,234 1 5
OMEPRAZOLE 820 784 2 4
LOVASTATIN 793 773 3 19
METFORMIN HCL 670 653 4 8
ALENDRONATE SODIUM 495 491 5 23
ATORVASTATIN CALCIUM 378 365 6 14
SIMVASTATIN 369 353 7 2
NEXIUM 330 328 8 60
TRIAMTERENE-HCTZ 309 300 9 36
TAMSULOSIN HCL 290 280 10 25
LACTULOSE 283 278 11 133
METOPROLOL SUCCINATE 279 274 12 18
DIOVAN 272 259 13 49
LIDODERM 251 250 14 64
ZOLPIDEM TARTRATE 245 227 15 21
LOSARTAN POTASSIUM 214 210 16 13
MEGESTROL ACETATE 210 209 R 17 196
BENAZEPRIL HCL 207 206 18 80
CLOPIDOGREL 201 199 19 50
JANUVIA 200 200 20 81
LISINOPRIL 175 173 21 1
AMOXICILLIN 174 163 22 180
ACTOS 170 164 23 112
GLIPIZIDE 159 156 24 40
LEVOFLOXACIN 152 139 25 138
PLAVIX 144 143 26 84
ATENOLOL 129 109 27 12
RANITIDINE HCL 125 124 28 29
LEVOTHYROXINE SODIUM 121 120 29 3
CELEBREX 116 115 30 124
CLONIDINE HCL 115 114 31 85
CREON 113 112 32 156
FUROSEMIDE 110 97 33 7
ACTONEL 110 110 33 278
DONEPEZIL HCL 110 110 33 32
AZOR 101 101 36 285
NAPROXEN 97 97 37 107
CARVEDILOL 95 95 38 33
PIOGLITAZONE HCL 90 86 R 39 248
WARFARIN SODIUM 89 83 40 10
LIPITOR 87 86 41 89
METOCLOPRAMIDE HCL 86 86 42 134
ZETIA 84 61 43 93
LANTUS 83 71 44 37
FLUOCINOLONE ACETONIDE 80 79 45 332
TRIAMCINOLONE ACETONIDE 77 77 46 96
ALLOPURINOL 71 57 47 31
ACETAMINOPHEN-CODEINE 67 48 S3 48 109
DOXAZOSIN MESYLATE 67 64 48 74
IBANDRONATE SODIUM 65 60 50 262
AMLODIPINE BESYLATE-BENAZEPRIL 63 63 51 181
HYDROCODONE-ACETAMINOPHEN 63 51 S3 51 6
GABAPENTIN 58 58 53 17
JANUMET 56 43 54 202
GLIPIZIDE XL 55 45 55 142
FLUOCINONIDE 54 53 56 264
FLUTICASONE PROPIONATE 54 54 56 26
GLYBURIDE 52 50 R 58 71
PANTOPRAZOLE SODIUM 50 49 59 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.